Maine Marijuana News

A new law going into effect later this month will protect the rights of medical marijuana patients and establish regulations for the state’s fledgling medicinal cannabis industry. House Bill 2612, or the Oklahoma Medical Marijuana and Patient Protection Act, as the measure is also known, will go into effect on Friday, August 30.

Oklahoma lawmakers passed House Bill 2612 earlier this year to establish regulations after the medicinal use of cannabis was legalized by voters with the passage of State Question 788 in June 2018. Seen as a compromise between lawmakers intent on regulating the industry and patient advocates who campaigned for the constitutional amendment initiative, the Medical Marijuana and Patient Protection Act has also been referred to as the Unity Bill.

The measure enacts regulations for medical marijuana providers including packaging and labeling requirements. The new law also protects patient access by prohibiting strict requirements such as a ban on smokable cannabis flower or limits on the amount of THC in medical marijuana products.

Bill Protects Patients’ Jobs

House Bill 2612 also has employment protections for medical marijuana patients, including a ban on firing an employee or refusing to hire an applicant based “solely on the basis of a

Read More Here…

Over the last couple years, medical marijuana in Utah has been a hot and controversial subject. In what has become a protracted, back-and-forth process between state legislators, medical marijuana advocates, and other powerful players in the state, Utah’s medical marijuana program continues to undergo dramatic changes.

Now, state lawmakers are preparing to make another significant change. Specifically, they said they will soon eliminate a proposal to distribute medical cannabis through state and county health departments. Instead, medical marijuana in the state will be sold through a network of privately owned and operated dispensaries.

New Changes to Utah’s Medical Marijuana Program

As reported by local news source Fox 13 Salt Lake City, lawmakers are set to introduce the new change in a special session of the State Legislature.

Importantly, this change will overhaul the state’s planned system for distributing medical marijuana. Up until now, the state planned on using a “central fill” system. In this framework, all medical marijuana would be distributed and sold through state and local health departments.

The plan sparked controversy when it was passed at the end of 2018. Specifically, many medical marijuana advocates pointed out that the program would run into problems, as it essentially forces

Read More Here…

From Washington to main street, changes to U.S. drug policy are evident. CBD products line the aisles at supermarkets and convenience stores. And emboldened by a new law that permits hemp cultivation, states across America are considering the crop as a new agricultural cornerstone.

Those changes do not, however, extend to the U.S. military. The Department of Defense issued a stern warning to its servicemembers this week: steer clear of hemp-derived products such as cannabidiol, better known as CBD.

“It’s completely forbidden for use by any service member in any of the services at this point of time,” said Patricia Deuster, director of the Human Performance Laboratory at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, as quoted by Military.com.

The warning comes on the heels of similar guidelines issued by the nation’s sea services, with the Navy, Coast Guard and Marines all warning members that, despite changes to state and federal law, the military policy remains the same.

The need to clarify the policy stems in part from the Agriculture Improvement Act, better known as the 2018 Farm Bill, which legalized the regulated industrial production of hemp, a move that inspired several states to pursue cultivation

Read More Here…

NYSE-traded cannabis company Aphria Inc. (NYSE: APHA) (TSX:APHA) and ParcelPal Technology Inc. (CSE: PKG) (OTC: PTNYF) will be announcing later today a strategic partnership for the delivery of the former’s medical cannabis products.

According to information procured exclusively, ahead of a press release hitting the wire later today, distribution and delivery will commence in Calgary, Alberta, but expansion into other areas is expected to follow shortly. Aphria will be providing the cannabis products and online point of sale, while ParcelPal will be in charge of distribution, leveraging its delivery apps. Patients will also be able to track their deliveries in real time.

– Read the entire article at Forbes.

Read More Here…

For the fourth year in a row, Calgary will be going to pot during the second weekend in October for the Hempfest Cannabis Expo.

This year’s expo, the first since legalization in October 2018, will feature Canada’s first legal cannabis competition, the Hempfest Cup, and organizers’ expectations are high.

“What we’re kinda going after is something like the SIP awards in the liquor industry, where craft alcohol producers can send in a bottle and be judged, so that’s what it’s trying to model,” expo organizer Sacha Hockenhull said. “Cannabis producers can now enter a competition that ranks them against each other.”

The competition, which will run alongside the expo on Oct. 11 and 12 at the Big Four building at Stampede Park, is open to any Canadian who can legally grow cannabis, from personal-use growers to licensed producers (LP).

– Read the entire article at Calgary Herald.

Read More Here…

No matter how trendy cannabis might be today, there are still plenty of misconceptions. That’s reflected in the fact that, according to a Quinnipiac poll released last March, most Gen Zers, Millennials and Gen Xers are in favor of legalized marijuana, while baby boomers are divided and adults over 65 years old mostly said, “No thank you.”

What’s interesting, though, is nearly all the poll’s participants said they would support the legal use of medical marijuana as a treatment option if their doctor prescribes it. And indeed, a 2016 report by the International Centre for Science in Drug Policy found that a lifetime use of cannabis carried a low risk of dependence, affecting only nine percent of the people surveyed. Other data suggests that cannabis can contribute to a low risk of developing lethal damage to the heart, declines in IQ or schizophrenia, and some studies have noted cannabis’s benefits toward mitigating chronic pain, motor and non-motor symptoms of Parkinson’s disease, fibromyalgia, endometriosis, interstitial cystitis and even some types of cancer.

– Read the entire article at Entrepreneur.

Read More Here…